{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:36:42Z","timestamp":1789900602530,"version":"4.0.1"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01054","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T07:31:18Z","timestamp":1537515078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of Valproic Acid on Cerebral Nutrient Carriers' Expression in the Rat"],"prefix":"10.3389","volume":"9","author":[{"given":"Aniv","family":"Mann Brukner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Ben-Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaf","family":"Honig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Ekstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Eyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/sj.bjp.0706830","article-title":"The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver","volume":"149","author":"Eyal","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1528-1157.1996.tb00602.x","article-title":"Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study","volume":"37","author":"Gaillard","year":"1996","journal-title":"Epilepsia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1208\/s12248-017-0096-2","article-title":"Breaking bad: the structure and function of the blood-brain barrier in epilepsy","volume":"19","author":"Han","year":"2017","journal-title":"AAPS J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1158\/1078-0432.ccr-08-2048","article-title":"Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes","volume":"15","author":"Hauswald","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2967\/jnumed.108.054098","article-title":"18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization","volume":"50","author":"Jadvar","year":"2009","journal-title":"J. Nucl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1528-1157.1991.tb04671.x","article-title":"Effect of valproate on human cerebral glucose metabolism","volume":"32","author":"Leiderman","year":"1991","journal-title":"Epilepsia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.eplepsyres.2018.03.014","article-title":"Folate homeostasis in epileptic rats","volume":"142","author":"Mann","year":"2018","journal-title":"Epilepsy Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1111\/epi.13392","article-title":"Effects of valproic acid on the placental barrier in the pregnant mouse: optical imaging and transporter expression studies","volume":"57","author":"Meir","year":"2016","journal-title":"Epilepsia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: the role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/clpt.2012.44","article-title":"The UCSF-FDA TransPortal: a public drug transporter database","volume":"92","author":"Morrissey","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-pharmtox-010510-100556","article-title":"The expression and function of organic anion transporting polypeptides in normal tissues and in cancer","volume":"52","author":"Obaidat","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","article-title":"Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery","volume":"19","author":"Pardridge","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/epi.14078","article-title":"Adverse placental effects of valproic acid: studies in perfused human placentas","volume":"59","author":"Rubinchik-Stern","year":"2018","journal-title":"Epilepsia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/epi.13037","article-title":"Antiepileptic drugs alter the expression of placental carriers: an in vitro study in a human placental cell line","volume":"56","author":"Rubinchik-Stern","year":"2015","journal-title":"Epilepsia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1212\/WNL.53.7.1518","article-title":"The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism","volume":"53","author":"Spanaki","year":"1999","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/gtc.12456","article-title":"Epigenetic regulation of the glucose transporter gene Slc2a1 by beta-hydroxybutyrate underlies preferential glucose supply to the brain of fasted mice","volume":"22","author":"Tanegashima","year":"2017","journal-title":"Genes Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/jcbfm.1986.54","article-title":"Effect of phenytoin on human cerebral glucose metabolism","volume":"6","author":"Theodore","year":"","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/ana.410250519","article-title":"The effect of carbamazepine on cerebral glucose metabolism","volume":"25","author":"Theodore","year":"1989","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1212\/WNL.36.1.60","article-title":"Barbiturates reduce human cerebral glucose metabolism","volume":"36","author":"Theodore","year":"","journal-title":"Neurology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s1474-4422(15)00398-1","article-title":"The remarkable story of valproic acid","volume":"15","author":"Tomson","year":"","journal-title":"Lancet Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1474-4422(15)00314-2","article-title":"Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug","volume":"15","author":"Tomson","year":"","journal-title":"Lancet Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/me.2008-0179","article-title":"Glucose metabolism as a target of histone deacetylase inhibitors","volume":"23","author":"Wardell","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/jcb.20555","article-title":"Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro","volume":"96","author":"Wong","year":"2005","journal-title":"J. Cell Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11033-016-4015-x","article-title":"Validation of reference genes for quantitative real-time PCR in valproic acid rat models of autism","volume":"43","author":"Zhou","year":"2016","journal-title":"Mol. Biol. Rep."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01054\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T07:31:20Z","timestamp":1537515080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01054\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":28,"alternative-id":["10.3389\/fphar.2018.01054"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01054","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,21]]},"article-number":"1054"}}